Gujarat Based Eris Lifesciences to Offer IPO From June 16
Shital Jibhe / 09 Jun 2017
Gujarat-based Eris Lifesciences Limited develops, manufactures and commercialises branded pharmaceutical products in select therapeutic areas within the chronic and acute categories of the IPM, such as gastroenterology; cardiovascular; anti-diabetics; vitamins; and anti-infectives.
Gujarat-based Eris Lifesciences Limited develops, manufactures and commercialises branded pharmaceutical products in select therapeutic areas within the chronic and acute categories of the IPM, such as gastroenterology; cardiovascular; anti-diabetics; vitamins; and anti-infectives.The company is coming up with its initial public offering (IPO) on June 16,
The company will be issuing 28,875,000 equity shares through this IPO. The IPO issue will follow book building process. The issue opens on June 16 and closes on June 20, 2017. Additional details about the IPO are yet to be released.
Eris has outpaced the With a CAGR of 33.9% in chronic and 20.1% in acute therapy segment; Eris Lifesciences has outrun the Indian Pharmaceutical Market (IPM) growth. ChrysCapital, the private equity firm, which holds a 16.25% stake in the company, will sell all of its 22.34 million shares, while founder Amit Bakshi, who holds 39.97%, will sell his 0.5% stake, reported leading national business daily.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.